Musk says Tesla may ’tape out’ next-generation AI6 chips in December

Tesla CEO Elon Musk said Tesla may 'tape out' its next-generation AI6 chip in December. Samsung earlier clinched a $16.5 billion deal to supply AI chips to Tesla and says it plans to produce Tesla chips on its advanced 2-nanometre process in the second half of 2027. Musk framed the December timeline as optimistic ('with some luck and acceleration using AI'), creating a clear divergence between Tesla's internal optimism and Samsung's public production schedule, implying commercialization is likely later in 2027.

Analysis

Tesla nudging an earlier “tape-out” narrative has an outsized signaling effect vs. its engineering reality — markets treat a December tape-out as a near-term product call, but the value hinge is the multi-quarter yield and cost curve after wafer ramp. If Tesla actually controls a differentiated SoC at 2nm and captures wafer economics via a long-term Samsung slot, it compresses CPU+accelerator ASPs for vehicle autonomy and robotics, shifting gross-margin capture from system integrators (Mobileye/NVIDIA-like players) to Tesla and its foundry partner.

Second-order winners include firms with flexible wafer-supply contracts and capacitor/packaging vendors that benefit from a concentrated high-margin Tesla wafer book; losers are legacy Tier-1 suppliers whose roadmap assumes third-party compute stacks. A constrained Samsung 2nm ramp creates an allocation game — hyperscalers vs. an auto OEM with seasonal wafer needs — which can drive sporadic price concessions or priority bottlenecks that ripple into AI infrastructure cycles in 2027–2028.

Key catalysts to watch are (1) validation tape-out results and lab silicon performance in the 0–3 months after design freeze; (2) Samsung yield curve and published wafer-start cadence in H1–H2 2027; and (3) regulatory/export-control headlines that can delay cross-border design licensing. The high-conviction trade is time-structured: short-term headline volatility should be faded, while multi-year optionality is worth funding via low-cost long-dated convex instruments rather than outright equity exposure.

Key Decisions for Investors

• Buy TSLA Jan-2028 LEAP calls (allocate 1–2% NAV). Rationale: low-cost multi-year asymmetric upside if in-house SoC materially cuts per-inference cost and accelerates autonomy/robot revenue; target 30–60%+ upside over 18–36 months. Risk: full premium loss if design or yield fails; cap position size to limit binary event risk.
• Sell short-dated (1–3 month) TSLA straddle/IV vs buy long-dated calls (calendar) — collect near-term IV ahead of incremental Musk headlines and fund long convexity. Expect 20–40% IV compression if no December tape-out catalyst; risk large gap moves on surprise functional silicon leaks — keep 2–3% NAV max on short leg and hedge with delta.
• Buy 6–12 month TSLA puts as tail insurance if materially long shares (cost 1–2% NAV) — protects vs a 25–40% drawdown triggered by tape-out failure, Samsung yield shortfall, or regulatory export shocks.
• If you prefer a more market-neutral stance: long select foundry/fab-exposed names (Samsung 005930.KS or NVDA for hyperscaler exposure) vs short TSLA near-term momentum. Mechanism: capture wafer-cycle upside if Samsung monetizes large Tesla wafer book while shorting idiosyncratic hype in TSLA; size as 0.5–1% NAV pair with stop-losses at 10–15%.